Add-on interventions for the prevention of recurrent Clostridioides Difficile infection: A systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Add-on interventions for the prevention of recurrent Clostridioides Difficile infection: A systematic review and network meta-analysis

Published:2021-10 Issue: Volume:71 Page:102441
ISSN:1075-9964
Container-title:Anaerobe
language:en
Short-container-title:Anaerobe

Author:

Paschos Paschalis^ORCID,Ioakim Konstantinos^ORCID,Malandris Konstantinos,Koukoufiki Argyro,Nayfeh Tarek^ORCID,Akriviadis Evangelos,Tsapas Apostolos^ORCID,Bekiari Eleni^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology

Reference42 articles.

1. Burden of Clostridium difficile infection in the United States;Lessa;N. Engl. J. Med.,2015

2. Treatment of recurrent Clostridium difficile colitis: a narrative review;Hopkins;Gastroenterol Rep,2017

3. Clostridioides difficile: diagnosis and treatments;Guery;BMJ,2019

4. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA);McDonald;Clin. Infect. Dis.,2018

5. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations;Hutton;Ann. Intern. Med.,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clostridioides difficile infection, recurrence and the associated healthcare consumption in Sweden between 2006 and 2019: a population-based cohort study;BMC Infectious Diseases;2024-05-03

2. Clostridioides difficile recurrence in individuals with and without cancer: a Swedish population-based cohort study;Infection;2024-02-26

3. Gut Microbiota–Gut Metabolites and Clostridioides difficile Infection: Approaching Sustainable Solutions for Therapy;Metabolites;2024-01-22

4. RBX2660 (REBYOTA®) in preventing recurrence of Clostridioides difficile infection: a profile of its use in the USA;Drugs & Therapy Perspectives;2023-09-23

5. Clostridioides difficile resistance to antibiotics, including post-COVID-19 data;Expert Review of Clinical Pharmacology;2023-08-29